Home › Funds › ADAR1 Capital Management, LLC › NKTR

ADAR1 Capital Management, LLC position in NKTR

NEKTAR THERAPEUTICS COM NEW · Health Care

ADAR1 Capital Management, LLC reported holding 244,184 shares of NKTR (NEKTAR THERAPEUTICS COM NEW) in its Q2 2026 13F filing — a position valued at US$17.0M, representing 0.94% of its reported portfolio and ranking #26 among its reported holdings. ADAR1 Capital Management, LLC has disclosed NKTR holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)244.18K sh
Reported value held$17.05M
Portfolio Weight0.94%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's NKTR position evolved

ADAR1 Capital Management, LLC first disclosed a stake in NKTR in Q3 2024 at 67,754 shares (US$88K). The position peaked in Q2 2026 at 244,184 shares, worth US$17.0M. Across 8 filings, ADAR1 Capital Management, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 244,184 shares valued at US$17.0M — an increase of 82,932 shares quarter over quarter.. Notable position changes include a 77% trim in Q2 2025 (shares rose 120% over the following quarter), a 356% increase in Q3 2025 (shares fell 26% over the following quarter), a 124% increase in Q1 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 67.75K $88.08K New
Q4 2024 67.75K $63.01K Hold
Q1 2025 67.75K $46.07K Hold
Q2 2025 15.80K $408.17K Reduce
Q3 2025 72.01K $4.10M Add
Q4 2025 72.03K $3.05M Hold
Q1 2026 161.25K $11.60M Add
Q2 2026 244.18K $17.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTR and 13F data

NKTR (NEKTAR THERAPEUTICS COM NEW) is a Health Care company. 70 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), BVF INC/IL (US$166.9M), Vestal Point Capital, LP (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTR

All NKTR fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held NKTR?

ADAR1 Capital Management, LLC has disclosed NKTR holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is ADAR1 Capital Management, LLC's current position in NKTR?

As of Q2 2026, ADAR1 Capital Management, LLC holds 244.18K shares of NKTR (NEKTAR THERAPEUTICS COM NEW), valued at $17.05M, representing 0.94% of its reported portfolio and ranking #26.

Has ADAR1 Capital Management, LLC been buying or selling NKTR?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in NKTR. The position peaked in Q2 2026 at 244.18K shares.

Which other funds hold NKTR?

Other major institutional holders of NKTR include Two Seas Capital LP, BVF INC/IL, Vestal Point Capital, LP, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.